Effect of flavanols on bone turnover markers in individuals with type 2 diabetes – a 3-month randomized placebo-controlled FLAVA trial

by Komal Waqas, Mardin Rashid, Bram Eerden, Kirsten Berk, M. Carola Zillikens
Published 2021-04-01

Skin autofluoresence, a non-invasive biomarker of advanced glycation end-products (AGEs), is associated with frailty: The Rotterdam study

by Komal Waqas, Jinluan Chen, Katerina Trajanoska, Arfam Ikram, Fernando Rivadeneira, Trudy Voortman, M. Carola Zillikens
Published 2021-04-01

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

by Komal Waqas, Joana Lima Ferreira, Elena Tsourdi, Jean-Jacques Body, Peyman Hadji, M.C. Zillikens
Published 2021-06-01

Skin autofluorescence, a non-invasive biomarker for advanced glycation end-products, is associated with Sarcopenia: The Rotterdam study

by Komal Waqas, Jinluan Chen, Katerina Trajanoska, M. Arfan Ikram, Fernando Rivadeneira, Andre Uitterlinden, M. Carola Zillikens
Published 2020-10-01

Dietary Advanced Glycation End-Products (dAGEs) Intake and Bone Health: A Cross-Sectional Analysis in the Rotterdam Study

by Komal Waqas, Jinluan Chen, Bram C. J. van der Eerden, M. Arfan Ikram, André G. Uitterlinden, Trudy Voortman, M. Carola Zillikens
Published 2020-08-01